Australia markets close in 50 minutes

Assembly Biosciences, Inc. (ASMB)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
13.27+0.80 (+6.42%)
At close: 04:00PM EDT
12.82 -0.45 (-3.39%)
After hours: 07:43PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-61,228
-61,228
-93,092
-129,855
-62,152
Depreciation & amortisation
450
450
498
466
691
Deferred income taxes
-
-
0
-2,531
0
Stock-based compensation
5,119
5,119
6,593
5,237
21,853
Change in working capital
76,341
76,341
-2,122
-11,401
-30,309
Accounts receivable
901
901
-608
894
2,144
Accounts payable
-2,032
-2,032
-166
-1,939
2,867
Other working capital
22,488
22,488
-84,565
-96,492
-65,177
Other non-cash items
3,507
3,507
3,505
3,840
6,964
Net cash provided by operating activities
22,743
22,743
-84,463
-93,396
-62,957
Cash flows from investing activities
Investments in property, plant and equipment
-255
-255
-102
-3,096
-2,220
Purchases of investments
-133,922
-133,922
-27,583
-160,446
-193,188
Sales/maturities of investments
65,015
65,015
116,825
187,700
263,478
Net cash used for investing activities
-69,138
-69,138
90,640
26,515
68,070
Cash flows from financing activities
Common stock issued
13,689
13,689
325
52,806
5,452
Other financing activities
134,661
-
-
-
-
Net cash used provided by (used for) financing activities
13,818
13,818
614
53,064
7,599
Net change in cash
-32,577
-32,577
6,791
-13,817
12,712
Cash at beginning of period
52,418
52,418
45,627
59,444
46,732
Cash at end of period
19,841
19,841
52,418
45,627
59,444
Free cash flow
Operating cash flow
22,743
22,743
-84,463
-93,396
-62,957
Capital expenditure
-255
-255
-102
-3,096
-2,220
Free cash flow
22,488
22,488
-84,565
-96,492
-65,177